One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Negative Pressure Dressings to Prevent Surgical Site Infection After Emergency LaparotomyThe SUNRRISE Randomized Clinical Trial
doi : 10.1001/jama.2024.24764
March 11, 2025, Vol 333, No. 10, Pages 827-917
Simvastatin and Rifaximin in Decompensated CirrhosisA Randomized Clinical Trial
doi : 10.1001/jama.2024.27441
High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory FailureThe RENOVATE Randomized Clinical Trial
doi : 10.1001/jama.2024.26244
Racial Disparities in End-of-Life Home Health Use in Medicare Advantage vs Traditional Medicare
doi : 10.1001/jama.2024.27493
Trends in Preventive Aspirin Use by Atherosclerotic Cardiovascular Risk
doi : 10.1001/jama.2024.27333
Recent Developments in Women’s Health Research at the US National Institutes of Health
doi : 10.1001/jama.2024.25878
United States v Skrmetti—Testing the Transition to Politicized Regulation of Medicine
doi : 10.1001/jama.2024.28537
The Intersection of Climate Justice and Criminal JusticeExtreme Heat and Health Inequities in Carceral Facilities
doi : 10.1001/jama.2024.27843
Reevaluating Respiratory Support in Acute Respiratory Failure—Insights From the RENOVATE Trial and Implications for Practice
doi : 10.1001/jama.2024.25869
Is High-Flow Oxygen the Standard for All Patients With Acute Respiratory Failure?
doi : 10.1001/jama.2024.25906
Study Finds Most Older Adults Use Digital Health Technologies, Plus Some Surprises
doi : 10.1001/jama.2024.28224
Drinking Alcohol Causes Certain Cancers, So Why Don’t Labels Warn About That?
doi : 10.1001/jama.2025.0073
Landmark Study Aims to Enroll 100 000 Black Women to Investigate Their Cancer Risks and Outcomes
doi : 10.1001/jama.2025.0074
Permanent Contraception Procedures Increase Among Young Adults Post Dobbs
doi : 10.1001/jama.2025.0241
Systematic Review Examines GLP-1 Drugs’ Effectiveness and Safety in Patients Without Diabetes
doi : 10.1001/jama.2025.0242
